118 related articles for article (PubMed ID: 38715238)
1. Prognostic value and immunological role of MMRN1: a rising star in cancer.
Zhou Q; Liu Y; Zhou J; Zhang W
Nucleosides Nucleotides Nucleic Acids; 2024 May; ():1-22. PubMed ID: 38715238
[TBL] [Abstract][Full Text] [Related]
2. Multimerin 1 supports platelet function in vivo and binds to specific GPAGPOGPX motifs in fibrillar collagens that enhance platelet adhesion.
Leatherdale A; Parker D; Tasneem S; Wang Y; Bihan D; Bonna A; Hamaia SW; Gross PL; Ni H; Doble BW; Lillicrap D; Farndale RW; Hayward CPM
J Thromb Haemost; 2021 Feb; 19(2):547-561. PubMed ID: 33179420
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers.
Tai P; Wang Z; Chen X; Chen A; Gong L; Cheng Y; Cao K
Cancer Med; 2023 May; 12(10):11941-11959. PubMed ID: 36205192
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Multimerin 1 (MMRN1) expression in ovarian cancer.
Saini A; Chandra KB; Kumar V; Mathur SR; Sharma JB; Kumar S; Yadav S
Mol Biol Rep; 2020 Dec; 47(12):9459-9468. PubMed ID: 33263168
[TBL] [Abstract][Full Text] [Related]
5. GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
Chen G; Luo D; Zhong N; Li D; Zheng J; Liao H; Li Z; Lin X; Chen Q; Zhang C; Lu Y; Chan YT; Ren Q; Wang N; Feng Y
Front Immunol; 2022; 13():857308. PubMed ID: 35345673
[TBL] [Abstract][Full Text] [Related]
6. The functions of the A1A2A3 domains in von Willebrand factor include multimerin 1 binding.
Parker DN; Tasneem S; Farndale RW; Bihan D; Sadler JE; Sebastian S; de Groot PG; Hayward CP
Thromb Haemost; 2016 Jul; 116(1):87-95. PubMed ID: 27052467
[TBL] [Abstract][Full Text] [Related]
7. A systematic analysis of
Jiang Y; Wang X; Li L; He J; Jin Q; Long D; Liu C; Zhou W; Liu K
Front Genet; 2022; 13():926943. PubMed ID: 35991552
[No Abstract] [Full Text] [Related]
8. Platelet adhesion to multimerin 1 in vitro: influences of platelet membrane receptors, von Willebrand factor and shear.
Tasneem S; Adam F; Minullina I; Pawlikowska M; Hui SK; Zheng S; Miller JL; Hayward CP
J Thromb Haemost; 2009 Apr; 7(4):685-92. PubMed ID: 19175495
[TBL] [Abstract][Full Text] [Related]
9. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
[TBL] [Abstract][Full Text] [Related]
10. Multimerin-1 and cancer: a review.
Posner MG
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35132992
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analysis of prognostic and immunological role of IL4I1 in human tumors: a bulk omics research and single cell sequencing validation.
Chen B; Liu Y; He Y; Shen C
Discov Oncol; 2024 May; 15(1):139. PubMed ID: 38691253
[TBL] [Abstract][Full Text] [Related]
12. Analyses of cellular multimerin 1 receptors: in vitro evidence of binding mediated by alphaIIbbeta3 and alphavbeta3.
Adam F; Zheng S; Joshi N; Kelton DS; Sandhu A; Suehiro Y; Jeimy SB; Santos AV; Massé JM; Kelton JG; Cramer EM; Hayward CP
Thromb Haemost; 2005 Nov; 94(5):1004-11. PubMed ID: 16363244
[TBL] [Abstract][Full Text] [Related]
13. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
Zhang J; Wang K; Hainisayimu T; Li H
Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
[TBL] [Abstract][Full Text] [Related]
15. Pan-Cancer Analysis of Microfibrillar-Associated Protein 2 (MFAP2) Based on Bioinformatics and qPCR Verification.
Qiu Z; Xin M; Wang C; Zhu Y; Kong Q; Liu Z
J Oncol; 2022; 2022():8423173. PubMed ID: 35211173
[TBL] [Abstract][Full Text] [Related]
16. Cyclin B1: A potential prognostic and immunological biomarker in pan-cancer.
Chen Q; Ouyang L; Liu Q
Biomol Biomed; 2024 Apr; ():. PubMed ID: 38581717
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer.
Gao X; Bu H; Ge J; Gao X; Wang Y; Zhang Z; Wang L
J Cancer; 2023; 14(13):2431-2442. PubMed ID: 37670965
[No Abstract] [Full Text] [Related]
18. Genetic Alteration, Prognostic and Immunological Role of Acyl-CoA Synthetase Long-Chain Family Member 4 in a Pan-Cancer Analysis.
Yu Y; Sun X; Chen F; Liu M
Front Genet; 2022; 13():812674. PubMed ID: 35126480
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis Reveals USP45 as a Novel Putative Oncogene in Pan-Cancer.
Li K; Wang Q; Bian H; Chen Z; He H; Zhao X; Gong P
Front Mol Biosci; 2022; 9():886904. PubMed ID: 35836933
[No Abstract] [Full Text] [Related]
20. Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
Laszlo GS; Alonzo TA; Gudgeon CJ; Harrington KH; Gerbing RB; Wang YC; Ries RE; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Walter RB
Clin Cancer Res; 2015 Jul; 21(14):3187-95. PubMed ID: 25825478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
